Supplementary Figure 4 from Targeting of Mir34a–notch1 Axis Reduced Breast Cancer Stemness and Chemoresistance

Eun Young Park,EunSun Chang,Eun Ji Lee,Hyun-Woo Lee,Hyeok-Gu Kang,Kyung-Hee Chun,Yu Mi Woo,Hyun Kyung Kong,Je Yeong Ko,Hiromu Suzuki,Erwei Song,Jong Hoon Park

DOI: https://doi.org/10.1158/0008-5472.22403289.v1

2023-01-01

Abstract:Supplementary Figure 4. Overexpression of miR-34a by lentiviral system in primary cells.

What problem does this paper attempt to address?

Supplementary Figure 3 from Targeting of Mir34a–notch1 Axis Reduced Breast Cancer Stemness and Chemoresistance

Eun Young Park,EunSun Chang,Eun Ji Lee,Hyun-Woo Lee,Hyeok-Gu Kang,Kyung-Hee Chun,Yu Mi Woo,Hyun Kyung Kong,Je Yeong Ko,Hiromu Suzuki,Erwei Song,Jong Hoon Park

DOI: https://doi.org/10.1158/0008-5472.22403292.v1

2023-01-01

Abstract:Supplementary Figure 3. The relationship between Notch1 and miR-34 family members.
Supplementary Figure 2 from Targeting of Mir34a–notch1 Axis Reduced Breast Cancer Stemness and Chemoresistance

Eun Young Park,EunSun Chang,Eun Ji Lee,Hyun-Woo Lee,Hyeok-Gu Kang,Kyung-Hee Chun,Yu Mi Woo,Hyun Kyung Kong,Je Yeong Ko,Hiromu Suzuki,Erwei Song,Jong Hoon Park

DOI: https://doi.org/10.1158/0008-5472.22403298.v1

2023-01-01

Abstract:Supplementary Figure 2. Expression levels of Notch family in tumorsphere cells.
Data from Targeting of Mir34a–notch1 Axis Reduced Breast Cancer Stemness and Chemoresistance

Eun Young Park,EunSun Chang,Eun Ji Lee,Hyun-Woo Lee,Hyeok-Gu Kang,Kyung-Hee Chun,Yu Mi Woo,Hyun Kyung Kong,Je Yeong Ko,Hiromu Suzuki,Erwei Song,Jong Hoon Park

DOI: https://doi.org/10.1158/0008-5472.can-14-1140

IF: 11.2

2014-01-01

Cancer Research

Abstract:Abstract Human breast cancers include cancer stem cell populations as well as nontumorigenic cancer cells. Breast cancer stem cells have self-renewal capability and are resistant to conventional chemotherapy. miRNAs regulate the expression of many target genes; therefore, dysregulation of miRNAs has been associated with the pathogenesis of human diseases, including cancer. However, a role for miRNA dysregulation in stemness and drug resistance has yet to be identified. Members of the miR34 family are reportedly tumor-suppressor miRNAs and are associated with various human cancers. Our results confirm that miR34a expression was downregulated in MCF7/ADR cells compared with MCF7 cells. We hypothesized that this reduction was due to the p53 (TP53) mutation in MCF7/ADR cells. In this study, we found that primary and mature miR34a were suppressed by treatment with p53 RNAi or the dominant-negative p53 mutant in MCF7 cells. Ectopic miR34a expression reduced cancer stem cell properties and increased sensitivity to doxorubicin treatment by directly targeting NOTCH1. Furthermore, tumors from nude mice treated with miR34a were significantly smaller compared with those of mice treated with control lentivirus. Our research suggests that the ectopic expression of miR34a represents a novel therapeutic approach in chemoresistant breast cancer treatment. Cancer Res; 74(24); 7573–82. ©2014 AACR.
Supplementary Methods, Figure Legends from Targeting of Mir34a–notch1 Axis Reduced Breast Cancer Stemness and Chemoresistance

Eun Young Park,EunSun Chang,Eun Ji Lee,Hyun-Woo Lee,Hyeok-Gu Kang,Kyung-Hee Chun,Yu Mi Woo,Hyun Kyung Kong,Je Yeong Ko,Hiromu Suzuki,Erwei Song,Jong Hoon Park

DOI: https://doi.org/10.1158/0008-5472.22403286.v1

2023-01-01

Abstract:Supplementary Methods, Figure Legends
Supplementary Figures 1-6 from Loss of SNAIL Regulated Mir-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells

PengXu Qian,Arindam Banerjee,Zheng-Sheng Wu,Xiao Zhang,Hong Wang,Vijay Pandey,Wei-Jie Zhang,Xue-Fei Lv,Sheng Tan,Peter E. Lobie,Tao Zhu

DOI: https://doi.org/10.1158/0008-5472.22395998

2023-01-01

Abstract:PDF file - 1291K, FIGURE S1: Representative data of genomic real-time PCR screening for DNA copy numbers of aberrant microRNAs on human chromosome 3p in breast carcinoma and the correlation between expression levels of miR-128 and ARPP21; FIGURE S2: miR-128 depletion confers non-tumorigenic MCF-10A cells with a malignant phenotype in vitro; FIGURE S3: Forced expression of miR-128 alters the morphology and reduces migration and invasion of MCF-7 cells in vitro, whereas miR-128 depletion confers non-tumorigenic HBL-100 cells with a malignant phenotype in vitro; FIGURE S4: miR-128 depletion confers a malignant phenotype on non-tumorigenic MCF-10A cells in vivo and miR-128 represses the CD44+CD24 Neg/Low population in mammary carcinoma cells; FIGURE S5: Interactions between miR-128 and its binding targets; FIGURE S6: Luciferase assay for promoter activity
Supplementary Figure 3 from Downregulation of Mir-452 Promotes Stem-Like Traits and Tumorigenicity of Gliomas

Liping Liu,Kun Chen,Jueheng Wu,Ling Shi,Bo Hu,Shiyuan Cheng,Mengfeng Li,Libing Song

DOI: https://doi.org/10.1158/1078-0432.22452474

2023-01-01

Abstract:miR-452 directly targets Bmi-1, LEF1 and TCF4.
Supplementary Figure 4 from Downregulation of Mir-452 Promotes Stem-Like Traits and Tumorigenicity of Gliomas

Liping Liu,Kun Chen,Jueheng Wu,Ling Shi,Bo Hu,Shiyuan Cheng,Mengfeng Li,Libing Song

DOI: https://doi.org/10.1158/1078-0432.22452471

2023-01-01

Abstract:miR-452 overexpression represses Wnt/β-catenin signaling.
Supplementary Materials and Methods from Loss of SNAIL Regulated Mir-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells

PengXu Qian,Arindam Banerjee,Zheng-Sheng Wu,Xiao Zhang,Hong Wang,Vijay Pandey,Wei-Jie Zhang,Xue-Fei Lv,Sheng Tan,Peter E. Lobie,Tao Zhu

DOI: https://doi.org/10.1158/0008-5472.22395995

2023-01-01

Abstract:PDF file - 190K, Includes patient and specimen data, reagent information, miRNA and siRNA transfection, and statistical analysis. Also includes supplementary references
Supplemental Data from Loss of Estrogen-Regulated MIR135A1 at 3p21.1 Promotes Tamoxifen Resistance in Breast Cancer

Weijie Zhang,Mingming Wu,Qing-Yun Chong,Min Zhang,Xiao Zhang,Lan Hu,Yanghao Zhong,Pengxu Qian,Xiangjun Kong,Sheng Tan,Gaopeng Li,Keshuo Ding,Peter E. Lobie,Tao Zhu

DOI: https://doi.org/10.1158/0008-5472.22425688.v1

2023-01-01

Abstract:Supplementary table S1 lists all the sequence of miR-135a mimic, siRNAs, shRNAs, and primers for plasmid construction, ChIP assay, and qRT-PCR used in this study. Supplementary table S2 shows the information of antibodies used in this study. Supplementary table S3 and S4 show the correlation of MIR135A1 deletion and low miR-135a-1 with the clinicopathologic features of breast cancer in the TCGA breast tumors, respectively. Supplementary table S5 lists genes including EMT markers, ERα cofactors and interacting proteins, and predicted miR-135a targets which expression levels negatively correlate with miR-135a in breast tumors. Supplementary figure S1 shows that the copy number of MIR135A1 gene and the expression levels of pri-miR-135a-1 are decreased in breast cancer. Supplementary figure S2 shows that miR-135a is a tumor suppressor gene in T47D and MDA-MB-231 cells and inhibits EMT of breast cancer cells. Supplementary figure S3 shows that miR-135a impairs the in vivo tumor growth. Supplementary figure S4 shows that the transcription of MIR135A1 positively correlates with E2-ERα axis. Supplementary figure S5 shows that miR-135a modulates the estrogen independent growth and the response to tamoxifen in ERα+ breast cancer cells. Supplementary figure S6 shows the validation of miR-135a targets in breast cancer cells. Supplementary figure S7 shows that miR-135a modulates ERα-ERK-AKT crosstalk.
Supplementary Figure 2 from Mir-186 Downregulation Correlates with Poor Survival in Lung Adenocarcinoma, Where It Interferes with Cell-Cycle Regulation

Junchao Cai,Jueheng Wu,Huizhong Zhang,Lishan Fang,Yongbo Huang,Yi Yang,Xun Zhu,Rong Li,Mengfeng Li

DOI: https://doi.org/10.1158/0008-5472.22397618.v1

2023-01-01

Abstract:PDF file - 24K, Real-time analysis of miR-186 expression in A549 and SK-MES-1 cells transfected with anti-miR-186 (Anti-miR) or NC oligonucleotides
Supplementary Figure 1 from Mir200c Attenuates P-gp–Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer

Hua Sui,Guo-Xiang Cai,Shu-Fang Pan,Wan-Li Deng,Yu-Wei Wang,Zhe-Sheng Chen,San-Jun Cai,Hui-Rong Zhu,Qi Li

DOI: https://doi.org/10.1158/1535-7163.22501866.v1

2023-01-01

Abstract:Supplementary Figure 1: miRNAs in the parental cells with those of MDR cells in colorectal cancer using miRNA microarray.
Supplementary Figure 2 from Mir-205 Targets PTEN and PHLPP2 to Augment AKT Signaling and Drive Malignant Phenotypes in Non–Small Cell Lung Cancer

Junchao Cai,Lishan Fang,Yongbo Huang,Rong Li,Jie Yuan,Yi Yang,Xun Zhu,Baixue Chen,Jueheng Wu,Mengfeng Li

DOI: https://doi.org/10.1158/0008-5472.22398032

2023-01-01

Abstract:PDF file, 51K, Real-time analysis of miR-205 expression in H460 and H596 cells transduced with control vector or miR-205 (A), or transfected with anti-miR-186 (Anti-miR) or NC oligonucleotides (B).
Supplementary Figures 1-6 from The miR-17-92 Cluster of MicroRNAs Confers Tumorigenicity by Inhibiting Oncogene-Induced Senescence

Lixin Hong,Maoyi Lai,Michelle Chen,Changchuan Xie,Rong Liao,Young Jun Kang,Changchun Xiao,Wen-Yuan Hu,Jiahuai Han,Peiqing Sun

DOI: https://doi.org/10.1158/0008-5472.22385181

2023-01-01

Abstract:Supplementary Figures 1-6 from The miR-17-92 Cluster of MicroRNAs Confers Tumorigenicity by Inhibiting Oncogene-Induced Senescence
Supplementary Figures 1 - 15 from MicroRNA100 Inhibits Self-Renewal of Breast Cancer Stem–like Cells and Breast Tumor Development

Lu Deng,Li Shang,Shoumin Bai,Ji Chen,Xueyan He,Rachel Martin-Trevino,Shanshan Chen,Xiao-yan Li,Xiaojie Meng,Bin Yu,Xiaolin Wang,Yajing Liu,Sean P. McDermott,Alexa E. Ariazi,Christophe Ginestier,Ingrid Ibarra,Jia Ke,Tahra Luther,Shawn G. Clouthier,Liang Xu,Ge Shan,Erwei Song,Herui Yao,Gregory J. Hannon,Stephen J. Weiss,Max S. Wicha,Suling Liu

DOI: https://doi.org/10.1158/0008-5472.22404500

2023-01-01

Abstract:Figure S1. Comparison of ALDH-positive population in different breast cancer cell lines and primary xenografts (UM2, MC1, UM1). Figure S2. mir-100 overexpression decreases ki67+ population in vitro. Figure S3. mir-100 overexpression inhibits the proliferation of both ALDH+ population and ALDH- population. Figure S4. mir-100 inhibits tumor growth of SUM149, MCF7 and T47D in NOD/SCID mice. Figure S5. mir-100 expression is higher in the tumor cells from mir-100 group compared to that from CTRL group. Figure S6. The percentage of ALDH+ cells in both primary CTRL and secondary CTRL tumors were increased compared to the parental cells injected. Figure S7. mir-100 expression is higher in the tumor cells from mir-100 induction groups with DOX (Late and Early) compared to that from CTRL group. Figure S8. mir-100 overexpression is necessary to maintain the inhibition of SUM159 tumor growth in NOD/SCID mice. Figure S9. mir-100 knockdown increases tumor growth in vivo. Figure S10. mir-100 inhibits metastasis of Both Total (Unseparated) and ALDH+ SUM159 cells in vivo. Figure S11. Identification of direct targets of mir-100. Figure S12. Knockdown of mir-100 targets mimic the effects of mir-100 overexpression. Figure S13. Verification of SMARCA5 and SMARCD1 level by Western blot. Figure S14. SMARCA5 and SMARCD1 are direct and functional targets of mir-100 in SUM149 cells. Figure S15. Kaplan-Meier survival curves based on the expression of SMARCA5 and SMARCD1.
Supplementary Figure 4 from Inhibition of Mir-17 and Mir-20A by Oridonin Triggers Apoptosis and Reverses Chemoresistance by Derepressing BIM-S

Hengyou Weng,He Huang,Bo Dong,Panpan Zhao,Hui Zhang,Liang‐Hu Qu

DOI: https://doi.org/10.1158/0008-5472.22401537.v1

2023-01-01

Abstract:PDF file - 32KB, Effects of miRNA inhibitors of the miR-17-19b cluster on the expression of BIM-S.
Supplementary Figure 1 from Mirna-145 Targets V-Ets Erythroblastosis Virus E26 Oncogene Homolog 1 to Suppress the Invasion, Metastasis, and Angiogenesis of Gastric Cancer Cells

Liduan Zheng,Jiarui Pu,Quincy Teng,Qiang Meng,Dan Li,Xuenan Xuan,Kai Huang,Qiangsong Tong

DOI: https://doi.org/10.1158/1541-7786.22510512.v1

2023-01-01

Abstract:PDF file - 17K, Effects of miR-145 on the proliferation of gastric cancer cells
Supplementary Table 2 from MicroRNA100 Inhibits Self-Renewal of Breast Cancer Stem–like Cells and Breast Tumor Development

Lu Deng,Li Shang,Shoumin Bai,Ji Chen,Xueyan He,Rachel Martin-Trevino,Shanshan Chen,Xiao-yan Li,Xiaojie Meng,Bin Yu,Xiaolin Wang,Yajing Liu,Sean P. McDermott,Alexa E. Ariazi,Christophe Ginestier,Ingrid Ibarra,Jia Ke,Tahra Luther,Shawn G. Clouthier,Liang Xu,Ge Shan,Erwei Song,Herui Yao,Gregory J. Hannon,Stephen J. Weiss,Max S. Wicha,Suling Liu

DOI: https://doi.org/10.1158/0008-5472.22404491.v1

2023-01-01

Abstract:Clinical stages and the percentage of ALDH1+ cells and mir-100+ cells of the 94 patients.
Supplementary Figure 3 from Mirna-145 Targets V-Ets Erythroblastosis Virus E26 Oncogene Homolog 1 to Suppress the Invasion, Metastasis, and Angiogenesis of Gastric Cancer Cells

Liduan Zheng,Jiarui Pu,Teng Qi,Meng Qi,Dan Li,Xuan Xiang,Kai Huang,Qiangsong Tong

DOI: https://doi.org/10.1158/1541-7786.22510506

2023-01-01

Abstract:PDF file - 166K, Scratch migration assay of gastric cancer cells
Supplementary Figure 4 from A Regulatory Loop Involving miR-22, Sp1, and c-Myc Modulates CD147 Expression in Breast Cancer Invasion and Metastasis

Ling-Min Kong,Cheng-Gong Liao,Yang Zhang,Jing Xu,Yu Li,Wan Huang,Yi Zhang,Huijie Bian,Zhi-Nan Chen

DOI: https://doi.org/10.1158/0008-5472.22402877

2023-01-01

Abstract:PDF file - 61K, Luciferase assays the effect of miR-22 on Sp3 and Sp4 post-transcriptional regulation.
Microrna-34a Suppresses the Breast Cancer Stem Cell-Like Characteristics by Downregulating Notch1 Pathway

Le Kang,Jun Mao,Yajun Tao,Bo Song,Wei Ma,Ying Lu,Lijing Zhao,Jiazhi Li,Baoxue Yang,Lianhong Li

DOI: https://doi.org/10.1111/cas.12656

IF: 5.7

2015-01-01

Cancer Science

Abstract:MicroRNAs play pivotal roles in cancer stem cell regulation. Previous studies have shown that microRNA-34a (miR-34a) is downregulated in human breast cancer. However, it is unknown whether and how miR-34a regulates breast cancer stem cells. Notch signaling is one of the most important pathways in stem cell maintenance and function. In this study, we verified that miR-34a directly and functionally targeted Notch1 in MCF-7 cells. We reported that miR-34a negatively regulated cell proliferation, migration, and invasion and breast cancer stem cell propagation by downregulating Notch1. The expression of miR-34a was negatively correlated with tumor stages, metastasis, and Notch1 expression in breast cancer tissues. Furthermore, overexpression of miR-34a increased chemosensitivity of breast cancer cells to paclitaxel (PTX) by downregulating the Notch1 pathway. Mammosphere formation and expression of the stemness factor ALDH1 were also reduced in the cells treated with miR-34a and PTX compared to those treated with PTX alone. Taken together, our results indicate that miR-34a inhibited breast cancer stemness and increased the chemosensitivity to PTX partially by downregulating the Notch1 pathway, suggesting that miR-34a/Notch1 play an important role in regulating breast cancer stem cells. Thus miR-34a is a potential target for prevention and therapy of breast cancer.

Supplementary Figure 4 from Targeting of Mir34a–notch1 Axis Reduced Breast Cancer Stemness and Chemoresistance

Supplementary Figure 3 from Targeting of Mir34a–notch1 Axis Reduced Breast Cancer Stemness and Chemoresistance

Supplementary Figure 2 from Targeting of Mir34a–notch1 Axis Reduced Breast Cancer Stemness and Chemoresistance

Data from Targeting of Mir34a–notch1 Axis Reduced Breast Cancer Stemness and Chemoresistance

Supplementary Methods, Figure Legends from Targeting of Mir34a–notch1 Axis Reduced Breast Cancer Stemness and Chemoresistance

Supplementary Figures 1-6 from Loss of SNAIL Regulated Mir-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells

Supplementary Figure 3 from Downregulation of Mir-452 Promotes Stem-Like Traits and Tumorigenicity of Gliomas

Supplementary Figure 4 from Downregulation of Mir-452 Promotes Stem-Like Traits and Tumorigenicity of Gliomas

Supplementary Materials and Methods from Loss of SNAIL Regulated Mir-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells

Supplemental Data from Loss of Estrogen-Regulated MIR135A1 at 3p21.1 Promotes Tamoxifen Resistance in Breast Cancer

Supplementary Figure 2 from Mir-186 Downregulation Correlates with Poor Survival in Lung Adenocarcinoma, Where It Interferes with Cell-Cycle Regulation

Supplementary Figure 1 from Mir200c Attenuates P-gp–Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer

Supplementary Figure 2 from Mir-205 Targets PTEN and PHLPP2 to Augment AKT Signaling and Drive Malignant Phenotypes in Non–Small Cell Lung Cancer

Supplementary Figures 1-6 from The &lt;i&gt;miR-17-92&lt;/i&gt; Cluster of MicroRNAs Confers Tumorigenicity by Inhibiting Oncogene-Induced Senescence

Supplementary Figures 1 - 15 from MicroRNA100 Inhibits Self-Renewal of Breast Cancer Stem–like Cells and Breast Tumor Development

Supplementary Figure 4 from Inhibition of Mir-17 and Mir-20A by Oridonin Triggers Apoptosis and Reverses Chemoresistance by Derepressing BIM-S

Supplementary Figure 1 from Mirna-145 Targets V-Ets Erythroblastosis Virus E26 Oncogene Homolog 1 to Suppress the Invasion, Metastasis, and Angiogenesis of Gastric Cancer Cells

Supplementary Table 2 from MicroRNA100 Inhibits Self-Renewal of Breast Cancer Stem–like Cells and Breast Tumor Development

Supplementary Figure 3 from Mirna-145 Targets V-Ets Erythroblastosis Virus E26 Oncogene Homolog 1 to Suppress the Invasion, Metastasis, and Angiogenesis of Gastric Cancer Cells

Supplementary Figure 4 from A Regulatory Loop Involving miR-22, Sp1, and c-Myc Modulates CD147 Expression in Breast Cancer Invasion and Metastasis

Microrna-34a Suppresses the Breast Cancer Stem Cell-Like Characteristics by Downregulating Notch1 Pathway

Supplementary Figures 1-6 from The <i>miR-17-92</i> Cluster of MicroRNAs Confers Tumorigenicity by Inhibiting Oncogene-Induced Senescence